Analysis Of Income And Expense [Abstract]

Sopharma AD - Filing #6022425

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2023-12-31	2022-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	1 875 304 BGN	—	—	—	—	—	—	—	—	1 663 016 BGN	—	—	—	—
Material income and expense [abstract]
Finance income (cost)	9 495 BGN	—	—	—	—	—	—	—	—	6 113 BGN	—	—	—	—
Other operating income (expense)	20 821 BGN	—	—	—	—	—	—	—	—	13 042 BGN	—	—	—	—
Miscellaneous other operating expense	14 321 BGN	—	—	—	—	—	—	—	—	14 374 BGN	—	—	—	—
Expenses by nature [abstract]
Raw materials and consumables used	103 861 BGN	—	—	—	—	—	—	—	—	99 129 BGN	—	—	—	—
Services expense	88 579 BGN	—	—	—	—	—	—	—	—	70 126 BGN	—	—	—	—
Classes of employee benefits expense [abstract]
Employee benefits expense	170 740 BGN	—	—	—	—	—	—	—	—	147 829 BGN	—	—	—	—
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	55 872 BGN	—	—	—	—	—	—	—	—	52 099 BGN	—	—	—	—
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method	24 473 BGN	—	—	—	—	—	—	—	—	22 635 BGN	—	—	—	—
Share of other comprehensive income of associates and joint ventures accounted for using equity method, before tax [abstract]
Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, before tax	4 893 BGN	—	—	—	—	—	—	—	—	790,000 BGN	—	—	—	—
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss	3,000 BGN	—	—	—	—	—	—	—	—	99,000 BGN	—	—	—	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	103 789 BGN	1 766 BGN	30,000 BGN	94 589 BGN	3 591 BGN	99 976 BGN	3 813 BGN	65 110 BGN	892,000 BGN	70 465 BGN	1 047 BGN	72 476 BGN	5 355 BGN	5 427 BGN
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	99 976 BGN	—	—	—	—	—	—	—	—	65 110 BGN	—	—	—	—
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	3 813 BGN	—	—	—	—	—	—	—	—	5 355 BGN	—	—	—	—